New research is showing that the rana esculenta, or edible frog, of Europe could lead to the discovery of new classes of antibiotics, which is an urgent need in the medical industry. The abstract of the report states that the rana esculenta possesses an “attractive molecule for use in the development of new compounds for the treatment of infectious diseases.” Why this is important:

“Due to the widespread resistance of bacteria to the available drugs, the discovery of new classes of antibiotics is urgently needed, and naturally occurring antimicrobial peptides (AMPs) are considered promising candidates for future therapeutic use. Amphibian skin is one of the richest sources of such AMPs. “